Utility of prostate-specific antigen derivatives to minimize unnecessary magnetic resonance imaging in patients with prior negative prostate biopsy

被引：0
|
作者：
Song, S. H. [1 ]
Song, B. [2 ]
Hwang, S. I. [3 ]
Lee, H. J. [3 ]
Lee, H. [1 ]
Hong, S. K. [1 ]
Byun, S-s. [1 ]
Lee, S. [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Urol, Seongnam, South Korea
[2] Hanyang Univ Hosp, Urol, Seoul, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Radiol, Seongnam, South Korea
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.361
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
342P
引用
收藏
页码：S1533 / S1534
页数：2
相关论文
共 50 条
  • [31] Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen
    Lian, Huibo
    Zhuang, Junlong
    Wang, Wei
    Zhang, Bing
    Shi, Jiong
    Li, Danyan
    Fu, Yao
    Jiang, Xuping
    Zhou, Weimin
    Guo, Hongqian
    BMC UROLOGY, 2017, 17
  • [32] Evaluation of magnetic resonance imaging-based prostate-specific antigen density of the prostate in the diagnosis of prostate cancer
    Hoshii, Tatsuhiko
    Nishiyama, Tsutomu
    Toyabe, Shinichi
    Akazawa, Kohei
    Komatsu, Shuichi
    Kaneko, Masaaki
    Hara, Noboru
    Takahashi, Kota
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (04) : 305 - 310
  • [33] Management of rising prostate-specific antigen after a negative biopsy
    Levy D.A.
    Jones J.S.
    Current Urology Reports, 2011, 12 (3) : 197 - 202
  • [34] Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels
    Lichy, Matthias P.
    Anastasiadis, Aristotelis G.
    Aschoff, Philip
    Sotlar, Karl
    Eschmann, Susanne M.
    Pfannenberg, Christina
    Stenzl, Arnulf
    Claussen, Claus D.
    Schlemmer, Heinz-Peter
    UROLOGY, 2007, 69 (06) : 1208.e5 - 1208.e8
  • [35] Management of rising prostate-specific antigen following a negative biopsy
    Jones, J. Stephen
    CURRENT OPINION IN UROLOGY, 2010, 20 (03) : 198 - 203
  • [36] Is there an optimal prostate-specific antigen threshold for prostate biopsy?
    Stephan, Carsten
    Miller, Kurt
    Jung, Klaus
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (08) : 1215 - 1221
  • [37] The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies
    Goertz, Magdalena
    Radtke, Jan Philipp
    Hatiboglu, Gencay
    Schuetz, Viktoria
    Tosev, Georgi
    Guettlein, Maximilian
    Leichsenring, Jonas
    Stenzinger, Albrecht
    Bonekamp, David
    Schlemmer, Heinz-Peter
    Hohenfellner, Markus
    Nyarangi-Dix, Joanne Nyaboe
    EUROPEAN UROLOGY FOCUS, 2021, 7 (02): : 325 - 331
  • [38] A Prospective Study of Reducing Unnecessary Prostate Biopsy in Patients with High Serum Prostate-Specific Antigen with Consideration of Prostatic Inflammation
    Lee, An Gu
    Choi, Yong Hyeuk
    Cho, Sung Yong
    Cho, In Rae
    KOREAN JOURNAL OF UROLOGY, 2012, 53 (01) : 50 - 53
  • [39] Estimate of negative predictive value of prostate specific antigen parameters and multiparametric magnetic resonance imaging for excluding prostate cancer at biopsy
    Pecoraro, V.
    Trenti, T.
    CLINICA CHIMICA ACTA, 2019, 493 : S157 - S157
  • [40] Magnetic Resonance Imaging Guided Prostate Biopsy in Men With Repeat Negative Biopsies and Increased Prostate Specific Antigen EDITORIAL COMMENT
    Schilling, David
    Stenzl, Arnulf
    JOURNAL OF UROLOGY, 2010, 183 (02): : 527 - 528
12345